• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道羧基酯酶mRNA的一个非AUG定义的替代性开放阅读框产生了一个表位,该表位可被肾细胞癌反应性肿瘤浸润淋巴细胞在原位识别。

A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ.

作者信息

Ronsin C, Chung-Scott V, Poullion I, Aknouche N, Gaudin C, Triebel F

机构信息

Laboratoire d'Immunologie Cellulaire, Institut Gustave-Roussy, Villejuif, France.

出版信息

J Immunol. 1999 Jul 1;163(1):483-90.

PMID:10384152
Abstract

A number of Ags recognized by tumor-reactive T cells have been characterized, including nonmutated gene products and a variety of epitopes shown to arise from either mutated or alternatively processed transcripts. Here, we report that the screening of a cDNA library with an HLA-B7-restricted renal cell carcinoma-reactive T cell clone derived from tumor-infiltrating lymphocytes (TILs) that were clonally amplified in vivo (as assessed by TCRBV complementarity determining region-3 length distribution analysis) resulted in the isolation of a nonamer encoded by an alternative open reading frame (ORF) (a +1 frameshift) of the intestinal carboxyl esterase gene. This peptide binds HLA-B*0702-presenting molecules as assessed in an immunofluorescence-based peptide binding assay using transfected T2 cells. Constitutive expression of this alternative ORF protein was observed in all transformed HLA-B7+ renal cell lines that were recognized in cytotoxicity assays by the TILs. The intestinal carboxyl esterase gene is transcribed in renal cell carcinoma tumors as well as in normal liver, intestinal, or renal tissues. Mutation of the natural ATG translation initiation site did not alter recognition, indicating that frameshifting (i.e., slippage of the ribosome forward) and recoding are not involved. In addition, a point mutation of the three AUG codons that may be used as alternative translation initiation sites in the +1 ORF did not abolish recognition, whereas mutation of an upstream ACG codon did, indicating that the latter codon initiates the translation of the alternative ORF. These results further extend the types of Ags that can be recognized by tumor-reactive TILs in situ (i.e., leading to clonal T cell expansion).

摘要

多种可被肿瘤反应性T细胞识别的抗原已得到鉴定,包括未突变的基因产物以及多种由突变或可变剪接转录本产生的表位。在此,我们报告,用一个HLA - B7限制性肾细胞癌反应性T细胞克隆筛选cDNA文库,该克隆源自肿瘤浸润淋巴细胞(TILs),这些TILs在体内进行了克隆扩增(通过TCRBV互补决定区 - 3长度分布分析评估),结果分离出一种由肠羧基酯酶基因的可变开放阅读框(ORF)(+1移码)编码的九肽。在使用转染的T2细胞进行的基于免疫荧光的肽结合试验中评估发现,该肽与呈递HLA - B*0702的分子结合。在细胞毒性试验中被TILs识别的所有转化的HLA - B7 +肾细胞系中均观察到这种可变ORF蛋白的组成性表达。肠羧基酯酶基因在肾细胞癌肿瘤以及正常肝、肠或肾组织中均有转录。天然ATG翻译起始位点的突变并未改变识别,这表明移码(即核糖体向前滑动)和重新编码并不涉及。此外,在 +1 ORF中可能用作替代翻译起始位点的三个AUG密码子的点突变并未消除识别,而上游ACG密码子的突变则消除了识别,这表明后者密码子启动了可变ORF的翻译。这些结果进一步扩展了原位肿瘤反应性TILs(即导致克隆性T细胞扩增)可识别的抗原类型。

相似文献

1
A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ.肠道羧基酯酶mRNA的一个非AUG定义的替代性开放阅读框产生了一个表位,该表位可被肾细胞癌反应性肿瘤浸润淋巴细胞在原位识别。
J Immunol. 1999 Jul 1;163(1):483-90.
2
Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.黑色素瘤中NY-ESO-1/LAGE-1主要和非主要开放阅读框衍生的CTL表位的高效同步呈递
J Immunol. 2000 Dec 15;165(12):7253-61. doi: 10.4049/jimmunol.165.12.7253.
3
An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes.人类巨噬细胞集落刺激因子基因的一个可变开放阅读框可独立翻译,并编码一种由肿瘤浸润性CD8 T淋巴细胞识别的14个氨基酸的抗原肽。
J Exp Med. 2001 May 21;193(10):1189-98. doi: 10.1084/jem.193.10.1189.
4
A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma.一种在人肾细胞癌上被细胞毒性T淋巴细胞识别的热休克蛋白70-2突变体。
J Immunol. 1999 Feb 1;162(3):1730-8.
5
CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame.CD4+ Th2细胞对源自骆驼(CAMEL)的HLA-DR限制性表位的识别:一种在可变开放阅读框中翻译的肿瘤抗原。
J Immunol. 2003 Feb 1;170(3):1490-7. doi: 10.4049/jimmunol.170.3.1490.
6
Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes.一种新的黑色素瘤抗原MART-2的分离,该抗原含有一个被自体肿瘤浸润性T淋巴细胞识别的突变表位。
J Immunol. 2001 Feb 15;166(4):2871-7. doi: 10.4049/jimmunol.166.4.2871.
7
T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product.与肿瘤消退相关的T细胞识别细胞周期蛋白依赖性激酶抑制剂2A(CDKN2A)肿瘤抑制基因位点的移码产物和一种突变的HLA I类基因产物。
J Immunol. 2004 May 15;172(10):6057-64. doi: 10.4049/jimmunol.172.10.6057.
8
The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes.未完全剪接的gp100基因转录本的内含子区域编码一个可被黑色素瘤反应性肿瘤浸润淋巴细胞识别的表位。
J Immunol. 1997 Jul 1;159(1):303-8.
9
A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene.一种由人类TMSB4Y基因的非常规开放阅读框编码的新型HLA - A*3303限制性次要组织相容性抗原。
J Immunol. 2004 Dec 1;173(11):7046-54. doi: 10.4049/jimmunol.173.11.7046.
10
Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells.抗原特异性CD4 +调节性T细胞识别肿瘤细胞中独特表达的新型ARTC1肽配体。
J Immunol. 2005 Mar 1;174(5):2661-70. doi: 10.4049/jimmunol.174.5.2661.

引用本文的文献

1
Non-mutational neoantigens in disease.疾病中的非突变性新抗原。
Nat Immunol. 2024 Jan;25(1):29-40. doi: 10.1038/s41590-023-01664-1. Epub 2024 Jan 2.
2
The landscape of T cell antigens for cancer immunotherapy.癌症免疫治疗的 T 细胞抗原全景。
Nat Cancer. 2023 Jul;4(7):937-954. doi: 10.1038/s43018-023-00588-x. Epub 2023 Jul 6.
3
CrypticProteinDB: an integrated database of proteome and immunopeptidome derived non-canonical cancer proteins.隐匿蛋白数据库:一个整合了蛋白质组和免疫肽组衍生的非经典癌症蛋白的数据库。
NAR Cancer. 2023 Jun 1;5(2):zcad024. doi: 10.1093/narcan/zcad024. eCollection 2023 Jun.
4
Current and future perspectives on CAR-T cell therapy for renal cell carcinoma: A comprehensive review.嵌合抗原受体 T 细胞疗法治疗肾细胞癌的现状与展望:一篇全面综述。
Investig Clin Urol. 2022 Sep;63(5):486-498. doi: 10.4111/icu.20220103.
5
Therapeutic Cancer Vaccines-Antigen Discovery and Adjuvant Delivery Platforms.治疗性癌症疫苗——抗原发现与佐剂递送平台
Pharmaceutics. 2022 Jul 11;14(7):1448. doi: 10.3390/pharmaceutics14071448.
6
The Hidden Enemy Within: Non-canonical Peptides in Virus-Induced Autoimmunity.体内的隐藏敌人:病毒诱导自身免疫中的非经典肽
Front Microbiol. 2022 Feb 10;13:840911. doi: 10.3389/fmicb.2022.840911. eCollection 2022.
7
Implications of Antigen Selection on T Cell-Based Immunotherapy.抗原选择对基于T细胞的免疫疗法的影响。
Pharmaceuticals (Basel). 2021 Sep 29;14(10):993. doi: 10.3390/ph14100993.
8
Tumor-infiltrating CD8 T cells recognize a heterogeneously expressed functional neoantigen in clear cell renal cell carcinoma.肿瘤浸润 CD8 T 细胞识别透明细胞肾细胞癌中异表达的功能性新抗原。
Cancer Immunol Immunother. 2022 Apr;71(4):905-918. doi: 10.1007/s00262-021-03048-6. Epub 2021 Sep 7.
9
Understanding small ORF diversity through a comprehensive transcription feature classification.通过全面的转录特征分类来理解小 ORF 多样性。
DNA Res. 2021 Sep 13;28(5). doi: 10.1093/dnares/dsab007.
10
Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinoma.晚期肾细胞癌的抗原特异性 T 细胞免疫治疗现状。
Hum Vaccin Immunother. 2021 Jul 3;17(7):1882-1896. doi: 10.1080/21645515.2020.1870846. Epub 2021 Mar 5.